United-Guardian Q1 2025 Earnings: Revenue Down 24%, EPS Falls to $0.12
ByAinvest
Saturday, May 10, 2025 8:17 am ET1min read
ASH--
The decrease in earnings was primarily attributed to a significant drop in cosmetic ingredients sales, which declined by 63% due to reduced orders from Ashland Specialty Ingredients (ASI) caused by excess inventory in China. However, the company noted positive developments in other segments, with medical lubricant sales increasing by 43% and pharmaceutical sales growing by 23% [2].
The company's earnings per share (EPS) fell from $0.20 in Q1 2024 to $0.12 in Q1 2025. The profit margin also declined from 28% in Q1 2024 to 23% in Q1 2025, primarily due to the revenue decrease [3].
President Donna Vigilante stated, "We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant and pharmaceutical businesses, the main reason for the decrease in sales and earnings was due to a decrease in our cosmetic ingredient business." She also expressed concerns about potential impacts from U.S. tariffs on imports from various countries [2].
United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients. The company's stock is listed on the NASDAQ under the ticker symbol UG.
References:
[1] https://www.rttnews.com/3537321/united-guardian-inc-q1-profit-declines.aspx
[2] https://www.stocktitan.net/news/UG/united-guardian-reports-first-quarter-v17dogk8xu19.html
[3] https://www.marketscreener.com/quote/stock/UNITED-GUARDIAN-INC-5138979/news/United-Guardian-Inc-Reports-Earnings-Results-for-the-First-Quarter-Ended-March-31-2025-49880992/
UG--
United-Guardian reported Q1 2025 earnings with revenue down 24% to $2.48m, net income down 39% to $560.9k, and EPS down to $0.12 from $0.20 in Q1 2024. The decrease in profit margin was driven by lower revenue, down to 23% from 28% in Q1 2024.
United-Guardian Inc. (UG) reported its first-quarter 2025 earnings, showing a substantial decline in financial performance. The company's revenue fell by 23.8% to $2.481 billion from $3.254 billion in the same period last year. Net income decreased by 39.4% to $560.89 million, or $0.12 per share, from $925.44 million, or $0.20 per share, in Q1 2024 [1][2].The decrease in earnings was primarily attributed to a significant drop in cosmetic ingredients sales, which declined by 63% due to reduced orders from Ashland Specialty Ingredients (ASI) caused by excess inventory in China. However, the company noted positive developments in other segments, with medical lubricant sales increasing by 43% and pharmaceutical sales growing by 23% [2].
The company's earnings per share (EPS) fell from $0.20 in Q1 2024 to $0.12 in Q1 2025. The profit margin also declined from 28% in Q1 2024 to 23% in Q1 2025, primarily due to the revenue decrease [3].
President Donna Vigilante stated, "We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant and pharmaceutical businesses, the main reason for the decrease in sales and earnings was due to a decrease in our cosmetic ingredient business." She also expressed concerns about potential impacts from U.S. tariffs on imports from various countries [2].
United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients. The company's stock is listed on the NASDAQ under the ticker symbol UG.
References:
[1] https://www.rttnews.com/3537321/united-guardian-inc-q1-profit-declines.aspx
[2] https://www.stocktitan.net/news/UG/united-guardian-reports-first-quarter-v17dogk8xu19.html
[3] https://www.marketscreener.com/quote/stock/UNITED-GUARDIAN-INC-5138979/news/United-Guardian-Inc-Reports-Earnings-Results-for-the-First-Quarter-Ended-March-31-2025-49880992/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet